Industry/Academia Translational Oncology Symposium 2012March 22, 2012
Moores Cancer Center |
Catriona JamiesonOctober 20, 2006Topics: Speakers: Catriona Jamieson Run Time: 15 minutes Cancer Stem Cell Research: From Bench to Bedside and Back |
Cancer Stem CellsAugust 3, 2007Topics: Speakers: Diane Simeone, Geoff Wahl, Susan Bonner-Weir Run Time: 2 hours 14 minutes
|
Alan TrounsonCalifornia Institute for Regenerative MedicineNovember 7, 2008Topics: Speakers: Alan Trounson Run Time: 29 minutes Special Address by the CEO of the California Institute for Regenerative Medicine |
Inder VermaSalk Institute for Biological StudiesNovember 7, 2008Topics: Speakers: Inder Verma Run Time: 03 minutes Introduction to Cancer Session |
Catriona JamiesonUC San DiegoNovember 7, 2008Topics: Speakers: Catriona Jamieson Run Time: 25 minutes The Molecular Evolution of Leukemic Stem Cells |
Hanna MikkolaUCLANovember 7, 2008Topics: Speakers: Hanna Mikkola Run Time: 25 minutes Defining and recreating the niche for hematopoietic stem cell self-renewal |
Inder VermaSalk Institute for Biological StudiesNovember 7, 2008Topics: Speakers: Inder Verma Run Time: 18 minutes Glioblastoma: The terminator |
Cancer PanelInder Verma, Catriona Jamieson, Hanna MikkolaNovember 7, 2008Topics: Speakers: Inder Verma, Catriona Jamieson, Hanna Mikkola Run Time: 11 minutes
|
Industry Wrap-Up PanelAlan Trounson, Neil Gibson, Stephen Laderman, Catriona Jamieson, Joydeep GoswamiNovember 7, 2008Topics: Speakers: Alan Trounson, Neil Gibson, Stephen Laderman, Catriona Jamieson, Roger Bingham, Joydeep Goswami Run Time: 49 minutes
|
EpigeneticsSiavash KurdistaniNovember 11, 2009Topics: Speakers: Siavash Kurdistani Run Time: 21 minutes
|
Clinical Applications of Stem Cell ResearchCatriona JamiesonNovember 11, 2009Topics: Speakers: Catriona Jamieson
|
Clinical Applications of Stem Cell ResearchWendy LevinNovember 11, 2009Topics: Speakers: Wendy Levin Run Time: 15 minutes
|
Andy BartkeSouthern Illinois UniversitySeptember 11, 2009Topics: Speakers: Andy Bartke Run Time: 32 minutes Andy Barke is Professor of Physiology and Director of the Department of Medicine at Southern Illinois University School of Medicine and a board... |
Gary RuvkunHarvard Medical SchoolSeptember 10, 2009Topics: Speakers: Gary Ruvkun Run Time: 1 hours 20 minutes Gary Ruvkun is Professor of Genetics at Harvard Medical School and his lab uses molecular genetics, genomics and C. elegans to study and understand... |
Judith CampisiThe Double-Edged Sword of Cellular SenescenceFebruary 1, 2010Topics: Speakers: Judith Campisi Judith Campisi is a Professor at the Buck Institute and holds a position at the Lawrence Berkeley National Laboratory. Her research is focused on... |
George MartinThe Aging-Disease RelationshipFebruary 5, 2010Topics: Speakers: George Martin George Martin is a Professor Emeritus in the Department of Pathology at the University of Washington School of Medicine and Director of the... |
Viruses: A Key to Understanding and Treating CancerClodagh O'SheaTopics: Speakers: Clodagh O'Shea Run Time: 42 minutes Clodagh O'Shea talks with Roger Bingham about what viruses have taught us about the genetics of cancer and ways of using that knowledge to create... |
Welcome and OverviewDavid Brenner, MD, UC San Diego School of Medicine & Thomas Kipps, MD, PhD, Moores Cancer CenterTopics: Speakers: David Brenner, Thomas Kipps Run Time: 15 minutes David Brenner is vice chancellor for Health Sciences and dean of the School of Medicine at the University of California, San Diego. In this role, he... |
Armed with Genomics, Is the Target in Sight for Myelodysplastic Syndromes?Azra Raza, MD, MDS Center, Columbia University Medical CenterTopics: Speakers: Azra Raza Run Time: 23 minutes Dr. Raza is the Director of the MDS Center at Columbia University in New York, NY. Dr. Raza completed her medical education in Pakistan, training in... |
Cilengitide, from Discovery to Clinical Development and BackDavid Cheresh, PhD, Moores Cancer CenterTopics: Speakers: David Cheresh Run Time: 25 minutes David Cheresh studies the mechanism of action of signaling networks that regulate cancer growth and metastasis and focuses on new strategies for... |
Targeting for Glioblastoma Patients with Cilengitide: Promises and ChallengesDavid Reardon, MD, Center for Neuro-Oncology, Dana-Farber Cancer InstituteTopics: Speakers: David Reardon Run Time: 32 minutes David Reardon is clinical director at Dana-Farber Cancer Institute's Center for Neuro-Oncology. His research interests are brain and spinal tumors,... |
Malignant Progenitor Re-ProgrammingCatriona Jamieson, MD, PhD, Moores Cancer CenterTopics: Speakers: Catriona Jamieson Run Time: 27 minutes Catriona Jamieson, MD, PhD is Associate Professor of Medicine in the Division of Hematology-Oncology and Director for Stem Cell Research at Moores... |
Stem Cells and CancerIrving Weissman, MD, Stanford School of MedicineTopics: Speakers: Irving Weissman Run Time: 40 minutes Irving L. Weissman's research encompasses the phylogeny and developmental biology of the cells that make up the blood-forming and immune systems. His... |
PAK Inhibitors for Cancer – Trailblazing a Path to the ClinicDavid Campbell, PhD, AfraxisTopics: Speakers: David Campbell Run Time: 14 minutes Prior to Afraxis, Dr. Campbell served as a member of the Phenomix Corporation executive team since 2003, most recently as an executive officer and... |
The Mouse that ROR'ed – Targeting Onco-Embryonic AntigensThomas Kipps, MD, PhD, Moores Cancer CenterTopics: Speakers: Thomas Kipps Run Time: 16 minutes Thomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Interim Director of the Moores Cancer Center. A... |
Understanding Rejection (How and Why) through the Melanoma ModelFrancesco Marincola, MD, National Institutes of HealthTopics: Speakers: Francesco Marincola Run Time: 30 minutes Dr. Marincola is Chief of the Infectious Disease and Immunogenetics Section in the Department of Transfusion Medicine at the Clinical Center of the... |
The New Center for Innovative Therapies: A University-Industry Partnership to Discover and Develop New Treatments and CuresMarye Anne Fox, PhD, Chancellor, University of California San DiegoTopics: Speakers: Marye Anne Fox Run Time: 04 minutes Marye Anne Fox, a world-renowned chemist, is the seventh chancellor of the University of California, San Diego and distinguished professor of... |
The New Center for Innovative Therapies: A University-Industry Partnership to Discover and Develop New Treatments and CuresThomas Kipps, MD, PhD, Moores Cancer CenterTopics: Speakers: Thomas Kipps Run Time: 09 minutes Thomas Kipps, MD, PhD, is Professor of Medicine, Evelyn and Edwin Tasch Chair in Cancer Research, and Interim Director of the Moores Cancer Center. A... |
Panel Discussion: Discovery to Therapies…It’s Changing and Quicklywith Duane Roth, Robert Abraham, PhD, Sandra Brown, PhD, Dennis Carson, MD, PhD, David Kabakoff, PhD, Jonathan Thomas, PhD, JD, and Carl WeissmanTopics: Speakers: Duane Roth, Robert Abraham, Sandra Brown, Dennis Carson, David Kabakoff, Jonathan Thomas, Carl Weissman Run Time: 1 hours 00 minutes Duane J. Roth is Chief Executive Officer and member of the Board of CONNECT. CONNECT is the globally recognized public benefits organization... |
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic MalignanciesWendy Levin, PfizerTopics: Speakers: Wendy Levin Run Time: 16 minutes
|
A patient on what it's like to have cancerLinda LoweTopics: Speakers: Linda Lowe Run Time: 08 minutes
|
Panel 1: Luke LairsonCancer and Cancer Stem CellsOctober 31, 2012Topics: Speakers: Luke Lairson Run Time: 17 minutes Luke Lairson received a B.Sc. in biochemistry from the University of Guelph, prior to completing a Ph.D. in chemistry at the University of... |
Panel 1: Ben SpikeCancer and Cancer Stem CellsOctober 31, 2012Topics: Speakers: Ben Spike Run Time: 20 minutes Ben Spike is a senior research associate in the laboratory of Dr. Geoffrey M. Wahl at the Salk Institute of Biological Studies. He is currently... |
Panel 1: Catriona JamiesonCancer and Cancer Stem CellsOctober 31, 2012Topics: Speakers: Catriona Jamieson Run Time: 27 minutes Catriona Jamieson studies the mutant stem cells and progenitor cells in myeloproliferative neoplasms, cells that can give rise to cancer stem cells.... |
For over a decade, TSN has been delivering the stories of science told by the world’s leading thinkers. What are they exploring and why? Why did they become scientists? How do they see science as part of the larger culture? And what lies ahead?
Our new podcast, Talking Science on TSN brings you their conversations with Roger Bingham from the TSN archive and fresh from the bench.
Find the podcast on your favorite podcast app, Soundcloud, iTunes, Stitcher, and RSS.
The Science Network has been available free of charge and without advertising for the past decade.
Gifts from Patrons, Benefactors - and people like you - have made this possible.
As we celebrate TSN@10, we acknowledge past and present donors, including:
SUSTAINING PATRONS
Diane and Rob Zeps
PATRONS
Mary Jane and Robert Engman
BENEFACTORS
The National Science Foundation
The Glenn Foundation
The Dana Foundation
The Kavli Foundation
The ResMed Foundation
The Swartz Foundation
Richard C. Atkinson
Shalom M. Blitz
Peter Farrell
Ernest W. Moody
Jennifer A. Moores
Gerry Ohrstrom
Andrew and Erna Viterbi